OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 29 citing articles:

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 52

Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1

Distinct Binding Mechanisms for Allosteric Sodium Ion in Cannabinoid Receptors
Soumajit Dutta, Balaji Selvam, Diwakar Shukla
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 3, pp. 379-389
Open Access | Times Cited: 25

Determination of the Negative Allosteric Binding Site of Cannabidiol at the CB1 Receptor: A Combined Computational and Site-Directed Mutagenesis Study
Pankaj Pandey, Ayat Zagzoog, Robert B. Laprairie, et al.
ACS Chemical Neuroscience (2025)
Closed Access

Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis
Zara Farooq, Pietro Delre, Stylianos Iliadis, et al.
ACS Pharmacology & Translational Science (2025)
Open Access

Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García‐García
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access

Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review
Matthew T. Welling, Myrna A. Deseo, Antony Bacic, et al.
Phytochemistry (2022) Vol. 201, pp. 113282-113282
Closed Access | Times Cited: 14

Endocannabinoid signaling in the central nervous system
César E. Martinez Ramirez, Gonzalo Ruiz‐Pérez, Todd M. Stollenwerk, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 5-35
Open Access | Times Cited: 14

Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation
Jiayi Yuan, Bo Ram Yang, Guanyu Hou, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103615-103615
Open Access | Times Cited: 8

Impact of Cannabinoid Compounds on Skin Cancer
Robert Ramer, Franziska Wendt, Felix Wittig, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1769-1769
Open Access | Times Cited: 10

Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform
David A. Bunsick, Jenna Matsukubo, Myron R. Szewczuk
Cancers (2023) Vol. 15, Iss. 4, pp. 1030-1030
Open Access | Times Cited: 5

Parsimonious Effect of Pentoxifylline on Angiogenesis: A Novel Pentoxifylline-Biased Adenosine G Protein-Coupled Receptor Signaling Platform
William Khoury, Ryan Trus, Xingyu Chen, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1199-1199
Open Access | Times Cited: 5

Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics
Simar Singh, Kaylin J. Ellioff, Michael R. Bruchas, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 162-173
Closed Access | Times Cited: 1

Ligand entry pathways control the chemical space recognized by GPR183
Viktoria M. S. Kjær, Tomasz Maciej Stępniewski, Brian Medel-Lacruz, et al.
Chemical Science (2023) Vol. 14, Iss. 39, pp. 10671-10683
Open Access | Times Cited: 4

Pharmacological Characterization of the Endocannabinoid Sensor GRABeCB2.0
Simar Singh, Dennis Sarroza, Anthony English, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 5, pp. 1250-1266
Open Access | Times Cited: 4

Pharmacological characterization of the endocannabinoid sensor GRABeCB2.0
Simar Singh, Dennis Sarroza, Anthony English, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023
Marc Lewis, Saeid Baroutian, Sara M. Hanning
Current Pain and Headache Reports (2023) Vol. 28, Iss. 3, pp. 109-118
Closed Access | Times Cited: 3

Thermodynamics and transport properties of CBD and Δ9-THC: A first attempt using molecular dynamics
Luis F. Salas-Guerrero, Cristian Buendía‐Atencio, Gustavo A. Orozco
Journal of Molecular Liquids (2022) Vol. 371, pp. 121048-121048
Closed Access | Times Cited: 5

GPCR Signaling: A Study of the Interplay Between Structure, Energy, and Function
Yann Chalopin
Proteins Structure Function and Bioinformatics (2024) Vol. 92, Iss. 12, pp. 1385-1397
Closed Access

Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
Miguel Á. Luján, Younghoon Kim, Linlin Zhang, et al.
Current topics in behavioral neurosciences (2024)
Closed Access

Specificities of Protein Homology Modeling for Allosteric Drug Design
Jakub Jakowiecki, Urszula Orzeł, Aleksandra Gliździńska, et al.
Methods in molecular biology (2023), pp. 339-348
Closed Access

The Endocannabinoid System as a Target in Cancer: Status and Future Perspectives
Estefanía Moreno, Milena Čavić, Enric I. Canela
Springer eBooks (2023), pp. 1-26
Closed Access

Page 1 - Next Page

Scroll to top